-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - This report is being generated twice a year.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_clinician.pdf
January 01, 2016 - Therapies for Clinically Localized Prostate Cancer
Therapies for Clinically Localized Prostate Cancer
Background
A National Institutes of Health (NIH) panel that convened
in 2011 recommended that AS—a strategy with curative
intent that involves regular monitoring of PSA levels and
repeat biopsies—should be offer…
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda_webinar_transcript2.pdf
August 27, 2012 - Because
the engaged stakeholders were over a two-year period across
these various research areas we … In year one we tended to focus on
simple important scores and use of rank and, again, because
of some … lessons we learned in year two we then moved
towards the use of analytic hierarchy process. … The stakeholders were engaged over, again, a
two-year period and involved three distinct phases. … What I am showing you here are some examples
of what we found in year one.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
January 01, 2018 - The results of the MTA covers a 10 year period and part of
what is meaningful to the results is how … period particularly from 14 months when the interventions
ended to 2 and 3 years as well as the 8-10 year … They were published in February of this year
online. … Such an approach that would save the
healthcare system nearly 4 billion dollars per year if it were … review and in the current one put together,
but that does not appear to be the case there is a 12 year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-treatment-ssri_research-protocol.pdf
June 15, 2010 - Evidence Report on the
Source: www.effectivehealthcare.ahrq.gov
Published Online: June 15, 2010
Evidence-based Practice Center Systematic Review Protocol
Project Title: Depression Treatment after Unsatisfactory Response to SSRIs when used as First-
line Therapy
I. Background and Objectives for the…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
December 17, 2013 - percent of individuals with breast cancer diagnosed between 2001-2007 had regional metastases, with a 5-
year … diagnosed with distant metastases,
most commonly to the bones, lungs, liver, or brain, and had a 5-year … Proposed fields for data abstraction
Data Element Endnote Reference Number, Author, Year
Study characteristics … Trends in mastectomy rates at the Mayo Clinic Rochester: effect of
surgical year and preoperative magnetic
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/registry-of-patient-registries_research-2014.pdf
January 01, 2014 - HbA1c level is
<8.0% during
the
measurement
year. … any face-to-face
encounters with a diagnosis of
diabetes, in any setting,
during the measurement year … or the year prior to the
measurement year. … occur at any time in the
member’s history, but must
have occurred by December
31 of the measurement year … (YEAR=missing) or principal
diagnosis (DX1=missing)
Population Joint
Commission
Acute myocardial
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
September 19, 2014 - the effectiveness
of long-term opioid therapy versus placebo or no opioid
therapy for long-term (>1 year … We focused on outcomes
reported after at least 1 year of opioid therapy, with the
exception of outcomes … after restricting inclusion to studies
that evaluated patients on opioid therapy for at least one
year … head-to-head trials
found few differences in pain relief between various long-
acting opioids at 1 year … Long-
term use of controlled-release oxycodone for noncancer
pain: results of a 3-year registry study
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0371_11-23-2010.pdf
January 01, 2010 - Population(s): Persons aged 18 years or over who currently have, or at any time during
the past year
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - health care system (e.g.,
patient outcomes, utilization, infrastructure, costs) is aggregated twice a year … This report is being generated twice a year. … , analysts predicted the cost for
lumacaftor/ivacaftor might be reduced to $150,000 to $200,000 a year … reportedly
predicted the cost for lumacaftor/ivacaftor could be reduced to $150,000 to $200,000 a year … /ivacaftor is expected to be similar to ivacaftor uptake, which was greater than 80% in
the first year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-app-f.xlsx
January 01, 2019 - evaluating external beam radiation therapy for the palliative treatment of metastatic bone disease
Author, Year … evaluating external beam radiation therapy for the palliative treatment of metastatic bone disease
Author, Year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-navigation-model-lung-cancer-rapid.pdf
December 01, 2018 - deaths.4 Although considerable progress had been made in the previous 20 years, the most recent
5-year … We
conducted a three-year SR search and a five-year primary study search in order to capture the
most … Systematic reviews relevant to Question 1
Study Information
Author, Year
• # Articles
• Navigation … Completed primary studies relevant to Question 2
Study Information
Author, year
• Study Type
• … Protocols and clinical trials relevant to Questions 2 and 3
Study Information
Author, Year
• Study
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wheelchair-service_research-protocol.pdf
July 01, 2010 - journals (i.e.,
Mobility Management, New Mobility, etc.) will be searched only for the last calendar year
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - This report is being generated twice a year. … In the 2-year cycle from 2009 to
2010, the age-adjusted obesity prevalence was about 36% among adult … Until about 1 year ago, orlistat, a pancreatic lipase inhibitor
that blocks about one-third of daily … The authors reported the following results:66
At 1 year, 55.4% of patients (883 of 1595) receiving … year 2 (67.9%) than in patients who
received placebo during year 2 (50.3%, P<0.001).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0576-150420.pdf
December 10, 2014 - Topic 0487 De-escalate Aggressive Behavior in Psychiatric Pts NSD FINAL CC clean
Comparative Effectiveness of Strategies to
De-escalate Aggressive Beha…
-
effectivehealthcare.ahrq.gov/sites/default/files/gorman.pdf
January 01, 2009 - Gorman_Asynchronous
Slide 1: Response to: Wiki-‐enabled
Communication…
Mark Gorman
Director
oÆ Survivorship Policy
National Coalition
for Cancer Survivorship
Silver Spring,
MD
Slide 2: About NCCS
• Founded
in
1986
• Mission: Advocate for Quali…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - bladder
disorders, significant renal
disease, uninvestigated
haematuria, >2 UTIs during
the previous year … uninvestigated
hematuria, current or a
history of ≥3 episodes of
urinary tract infection in the
preceding year … uninvestigated
hematuria and urinary tract
infection at washout or more
than twice during the prior
year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
January 01, 2014 - Eight-year clinical
outcomes of long-term enzyme replacement therapy for 884
children with Gaucher
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - Only nine studies
compared ACEIs and ARBs for periods longer than 1 year. … patient with cancer and
an 80-year-old patient with heart failure. … One study52 followed patients for 5 years, and approximately half of the
studies had at least 1 year … The most consistent result is that persistence increased
with age: patients in the 65-to-84-year-old … Continuation of initial antihypertensive
medication after 1 year of therapy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-nonsurgical-therapies_research-protocol.pdf
February 22, 2012 - NSCLC) is the leading cause of cancer-related mortality
worldwide, with over 1 million deaths per year … After complete surgical resection, the 5-year overall survival is around 70 percent
because of tumor